Table I.
Distribution of type of suspected multidrug-resistant (MDR)-TB patients by sex (n=2958)
| Type of MDR suspect | Total patients (n=2708)† n (%) | Males (n=1609) n (%) | Females (n=1099) n (%) |
|---|---|---|---|
| Treatment failure | 374 (13.81) | 227 (14.10) | 147 (13.37) |
| Retreatment case smear +ve at four month | 93 (3.43) | 59 (3.66) | 34 (3.09) |
| Contact of known MDR-TB case | 33 (1.21) | 16 (0.99) | 17 (1.54) |
| Smear +ve at diagnosis, retreatment case | 731 (26.99) | 450 (27.96) | 281 (25.56) |
| Any follow up smear +ve | 260 (9.60) | 151 (9.38) | 109 (9.91) |
| Smear –ve at diagnosis, retreatment case | 53 (1.95) | 23 (1.42) | 30 (2.72) |
| HIV-TB comorbidity | 7 (0.25) | 2 (0.12) | 5 (0.45) |
| Relapse | 486 (17.94) | 280 (17.40) | 206 (18.74) |
| Treatment after loss to follow up | 284 (10.48) | 188 (11.68) | 96 (8.73) |
| Others | 97 (3.58) | 48 (2.98) | 49 (4.45) |
| New patients | 290 (10.70) | 165 (10.25) | 125 (11.37) |
†Data not available for 250 patients (140 males and 110 females)